CSI Market
Sign In | Register

Recursion Pharmaceuticals Inc (RXRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access RXRX quarterly Balance Sheets →
The balance sheet data below highlights changes in Recursion Pharmaceuticals Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent743.29
Short-term Investments, Total0.00
Cash & Short-term Investments743.00
Accounts receivable0.00
Other Receivables, Net, Current24.65
Other Current Assets33.16
Prepaid Expense, Current AS11.74
Total Current Assets812.85
Equipment/Property/Plant Net103.93
Goodwill net162.16
Intangible Assets309.90
Other Assets, Noncurrent85.29
Restricted Cash Current4.59
Restricted Cash Noncurrent6.03
Operating Lease Right Of Use Asset45.34
Total Assets1,474.13
Liabilities
Accounts Payable, Current AC18.12
Accrued Liabilities, Current AC70.23
Long-term Debt and Capital Lease Obligations, Current DE9.09
Other Liabilities, Current50.27
Total Current Liabilities147.71
Long-term debt9.56
Total Long-term Debt9.56
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent185.99
Contract With Customer Liability Current37.61
Contract With Customer Liability Noncurrent114.01
Total Liabilities343.27
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock3,170.15
Retained Earnings / Accumulated Deficit-2,076.00
Other Equity36.72
Common Stockholder's Equity1,130.87
Total Stockholder's Equity1,130.87
Liabilities & Stockholder's Equity1,474.13
4 historic quarters locked

Sign in to unlock the full Recursion Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Recursion Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: rxrx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001601830-26-000039

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License